Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Haematologica|March 1, 1993
Recombinant human erythropoietin in the treatment of myelodysplastic syndromes. An interim reportM A Aloe Spiriti, M C Petti, R Latagliata, et al.
Leukemia & Lymphoma|January 1, 1993
Is recombinant human erythropoietin treatment in myelodysplastic syndromes worthwhile?M A Aloe Spiriti, M C Petti, R Latagliata, et al.
Leukemia|April 1, 1993
Mitoxantrone, etoposide and intermediate-dose Ara-C (MEC): an effective regimen for poor risk acute myeloid leukemiaA Spadea, M C Petti, P Fazi, et al.
European Journal of Haematology. Supplementum|January 1, 1990
Alpha-2b-interferon as single therapy for patients with chronic myeloid leukemia relapsing after T-cell depleted allogeneic bone marrow transplantationW Arcese, F R Mauro, M Screnci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2001
Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell'AdultoG Specchia, F Lo Coco, M Vignetti, et al.
Journal of Thrombosis and Haemostasis : JTH|June 20, 2014
Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factorsM Ruggeri, A Tosetto, F Palandri, et al.
Leukemia|January 17, 2003
The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trialS Keating, S Suciu, T de Witte, et al.
Leukemia|September 1, 1996
Outcome of patients with acute myeloid leukemia who failed to respond to a single course of first-line induction therapy: a GIMEMA study of 218 unselected consecutive patients. Gruppo Italiano Malattie Ematologiche Maligne dell'AdultoV Liso, P Iacopino, G Avvisati, et al.
Leukemia|May 24, 2003
Treatment of elderly patients (> or =60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocolsF Mandelli, R Latagliata, G Avvisati, et al.
Leukemia|August 26, 2006
Non-infusional vs intravenous consolidation chemotherapy in elderly patients with acute myeloid leukemia: final results of the EORTC-GIMEMA AML-13 randomized phase III trialU Jehn, S Suciu, X Thomas, et al.
Pageof 3